U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465653) titled 'A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction' on March 06.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable heart failure with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF).
Study Start Date: March 19
Study Type: INTERVENTIONAL
Condition:
Heart Failure With Reduced Ejection Fraction
Intervention:
DRUG: HJB647 low dose
Study drug low dose in capsule form
DRUG: HJB647 high dose
Study drug high dose in capsule form
OTHER: Placebo
Pla...